NeoGenomics, Inc.
Price Action
Technical Summary
EMERGING TRENDNeoGenomics, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 91), indicating clear outperformance against the broad market. Earnings growth of 35% provides fundamental context to the price action. However, with RSI at 83, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $12.57 | +15.32% | ABOVE |
| 50 SMA | $10.57 | +37.16% | ABOVE |
| 100 SMA | $9.65 | +50.23% | ABOVE |
| 150 SMA | $10.51 | +38.02% | ABOVE |
| 200 SMA | $10.32 | +40.56% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NEO in an uptrend right now?
NEO has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is NEO overbought or oversold?
NEO's RSI (14) is 83. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is NEO outperforming the market?
NEO has a Relative Strength (RS) Rating of 91 out of 99. Yes, NEO is a market leader, outperforming 91% of all stocks over the past 12 months.
Where is NEO in its 52-week range?
NEO is trading at $14.50, which is 93% of its 52-week high ($15.57) and 90% above its 52-week low ($4.72).
How volatile is NEO?
NEO has a Beta of 1.23 and 52-week volatility of 63%. It's more volatile than the S&P 500 - expect bigger swings.